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Cleaner <p>Cleaner is a method for removing uninformative and flawed probes from microarray experiment data, thus improving reproducibility  between replicate experiments.</p>
Abstract
Gene expression profiling technologies suffer from poor reproducibility across replicate
experiments. However, when analyzing large datasets, probe-level expression profile correlation
can help identify flawed probes and lead to the construction of truer probe sets with improved
reproducibility. We describe methods to eliminate uninformative and flawed probes, account for
dependence between probes, and address variability due to transcript-isoform mixtures. We test
and validate our approach on Affymetrix microarrays and outline their future adaptation to other
technologies.
Background
Gene expression profiling is a valuable technique for studying
cell phenotype at the molecular level. Microarray gene
expression profiling, in particular, is unquestionably the most
widely adopted molecular profiling technique, used virtually
throughout the life-sciences, and deep-sequencing based
approaches are slated to further improve our ability to moni-
tor gene transcripts in the cell. However, since the inception
of the technology, the accuracy of gene expression profiles has
been questioned due to relatively poor reproducibility [1-3].
Numerous studies have attempted to improve accuracy and
reproducibility by applying filtering methods and improving
data processing and normalization [4-7], but both technol-
ogy-specific and technology-independent aspects of the gath-
ering and analysis of this data modality remain challenging.
For instance, a recently addressed gene expression profile-
specific challenge is posed by probe designs that become rap-
idly outdated due to changes in genomic sequences and their
annotations, and probe-set remapping using up-to-date
genomic annotation has been repeatedly shown to improve
Affymetrix expression microarray accuracy [8,9]. To improve
reader comprehension, we note that in this correspondence
we address microarray expression profiling technical chal-
lenges at the probe level and we are careful to distinguish
between individual probes (that is, 25-mer oligonucleotide
sequences), Affymetrix probe sets (sets of 25-mer probes
designed to span a target region based on a UniGene cluster),
and our own probe clusters. Technology-independent chal-
lenges that are at best only partially resolved are related to tis-
sue-specific transcript isoforms, post-transcriptional
modifications, and polymorphisms that can affect measure-
ment accuracy in a context-specific fashion. Because of their
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complex and poorly understood nature, accounting for all of
these features individually is a prohibitive task, and techno-
logical advancements alone are not likely to resolve them.
We noticed that prior efforts to address these challenges were
mostly focused on improving accuracy for standalone expres-
sion measurements, and largely disregarded the increasing
availability of gene-expression profiles representing a diver-
sity of phenotypic or molecular contexts for the same cellular
system [10,11]. This diversity is quite valuable, as it allows for
monitoring transcript isoforms and increasing measurement
accuracy by assembling transcript-specific clusters of corre-
lated probes across large and diverse sample sets. Statistical
methods that take advantage of this diversity of expression
measurements can identify and even correct biases that typi-
cally result in measurement inaccuracies. We reasoned that if
distinct probes monitor the same transcript isoform, then
their measurements should be highly correlated across large
gene expression profile datasets. This simple idea, which has
not been previously used for the identification of informative
probes, can be used to substantially improve expression
measurement accuracy and to monitor alternative splice var-
iants in the cell. Our proposed algorithm, Cleaner, imple-
ments this idea for Affymetrix GeneChip microarrays and
may be extended in a straightforward fashion to other tech-
nologies.
To illustrate the algorithm, without loss of generality, we
focus on remapping, filtering and clustering probes in
Affymetrix GeneChip microarrays, one of the most popular
genome-wide expression profiling platforms for which a vari-
ety of large-scale datasets are available in public repositories,
including human B cell profiles on the U95Av2 platform [10],
breast carcinoma and high-grade glioma profiles on the
U133A and U133B platforms [12], and breast carcinoma, pro-
myelocytic leukemia, prostate cancer, and glioblastoma pro-
files on the U133A platform [11,13,14], among many others.
Cleaner improved cross-platform agreement between differ-
ential expression analyses of technical-replicate experiments
from 41.6% to 61.2%, suggesting that nearly 50% of the gene
expression measurements produced by these large-scale
studies can be significantly improved by Cleaner analysis. The
main ideas behind Cleaner are illustrated in Figure 1.
We compared Cleaner both to analyses using Affymetrix
annotation and AffyProbeMiner annotation [9]. The latter is
a recent effort focused on remapping and re-clustering micro-
array probes, and it compares favorably to other sequence-
alignment centric efforts. We measured inter- and intra-
microarray consistency by computing the correlation
between repeated GeneAtlas gene profiling experiments
using U133A, and by comparing gene sets identified as differ-
entially down-regulated in centroblasts relative to naïve B
cells using U95Av2 and U133plus2 platforms. We show that
annotation by Cleaner significantly and systematically
improved consistency across experiments and platforms,
thus both improving accuracy of downstream analysis and
simplifying the integration of experiments from multiple
sources. To quantify these improvements, we performed
quantitative reverse transcription real time PCR (qRT-PCR)
validation of the expression of FOXM1 and MYB in human B
cells, two genes that are mapped to multiple Affymetrix probe
sets. Our experiments suggest that several of these probe-sets
are conflicting and uninformative in the specific cellular con-
text. As such, they should be disregarded when analyzing
samples from naïve and centroblast B cells. Unlike other
annotations, by pooling all consistent matching probes on the
array, Cleaner annotation produced a single probe cluster per
gene and gave definitive expression estimates that we vali-
dated here. In general, we showed that thousands of genes
were associated with conflicting or uninformative Affymetrix
probe sets in this B cell dataset, and Cleaner identified and
resolved >95% of these instances.
Cleaner's approach is virtually technology-independent and
can be easily adapted to clustering probes from other micro-
array platforms as well as short reads from deep-sequencing
based approaches. For instance, probe clustering using data
from exon-arrays will improve the identification of the spe-
cific isoforms that are differentially expressed across the sam-
ples, thus removing those that are not informative and
significantly simplifying downstream analysis. Similarly,
clustering short overlapping transcript fragments according
to read multiplicity in deep-sequencing datasets may allow
for improved transcript and exon-boundary detection, help
estimate the frequency of splicing events, and help decon-
volve and assign origin for reads with homology to several
sites in the reference genome [15]. Finally, the substantial
accuracy improvement achieved using Cleaner suggests that
its use offers a unique opportunity to reevaluate inferences
made from past Affymetrix gene expression profiles, which
comprise 80% of the data-sets currently deposited in the
Gene Expression Omnibus (GEO) [16], and points to
Cleaner's potential impact on future microarray and deep-
sequencing gene expression profile experiments. Cleaner,
implemented in R and Python, is available for download from
Califano Lab [17].
Results
We begin by describing the Cleaner algorithm, and then show
that Cleaner probe clusters improve consistency across tech-
nical replicate experiments and across platforms by eliminat-
ing biased and flawed probes. We conclude with a targeted
study showing that probes in Affymetrix probe sets with
inconsistent behavior are regrouped into consistent and
informative probe clusters by Cleaner.
The Cleaner algorithm
Cleaner proceeds by (a) remapping individual probes to the
most recent RefSeq transcripts, (b) discarding probes
mapped to multiple genes or incorrect regions, (c) computinghttp://genomebiology.com/2009/10/12/R143 Genome Biology 2009,     Volume 10, Issue 12, Article R143       Alvarez et al. R143.3
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correlation between all probe pairs on the same gene, and
finally (d) organizing probes in clusters that are optimally
intra-correlated within the specific context. A detailed
description of each of these steps is given below.
Probe mapping to RefSeq genes
We mapped probe sequences to the transcripts in the RefSeq
database [18] dating 11 December 2008 using ZOOM [19] and
allowing for at most one mismatch per probe (each probe
sequence matched at least 24 transcript positions). We
matched against the positive orientation of RefSeq tran-
scripts only. Probes that matched multiple non-overlapping
genes were discarded, and each location in each matching
transcript was annotated.
Building clean probe clusters
Based on probe mapping to RefSeq transcripts and corre-
sponding genes, we constructed transcript-focused probe
clusters in three steps: 1, quality control for individual probes;
2, clustering of correlated probes; and 3, testing of probe-
cluster consistency. Probe clusters were used to create CDF
files for assigning quantitative probe-cluster intensity by
MAS5.
Step 1: probe consistency
We first established the consistency of each individual probe
based on its correlation to other probes that were mapped to
the same gene (neighbors) across microarray experiments. In
this gene-focused approach, the readout obtained from any
given probe is informative only if it is significantly correlated
with other probes mapping to the same gene. First, probe rea-
Cleaner on 152 B-cell samples profiled on U95Av2 chips Figure 1
Cleaner on 152 B-cell samples profiled on U95Av2 chips. (a) Probe consistency scores for four genes (distinguished by color) and their corresponding null 
density distributions. Dots represent probes and are plotted according to consistency scores (horizontal axis) and distances from the transcript end 
(vertical axis). Solid lines depict null density distributions and dotted vertical lines are drawn at their 99 percentile. Consistent probes are to the right of 
their respective dotted lines. (b) Unsupervised hierarchical clustering of probes mapping to MAX (all isoforms); naturally occurring probe clusters are 
highlight in red. (c) Relative distance between each consecutive cluster in the dendrogram in (b); the right-most point represents the distance between 
highlighted clusters in (b). (d) Three known isoforms for MAX and the mapping positions of probes belonging to the two Cleaner probe clusters for MAX; 
probes from probe cluster 4149.2 are mapped to the splice-variant fifth exon, and probes from 4149.1 measure a convolution of the two transcripts. (e) 
The mean of Pearson correlations between overlapping and neighboring probes depends on the distance between them, and it is closely modeled by an 
exponential function. (f) False discovery rate (FDR) as a function of the consistency score, as estimated by permutation testing; no probe-cluster with 
consistency scores higher than 4 were identified in permuted clusters. (g) Probe-cluster consistency scores are correlated to their MAS5-assigned 
intensity, as measured before pruning. However, the intersection between distributions for the 4,702 consistent probe clusters (red), 3,708 inconsistent 
probe clusters (blue), and all probe clusters (black line) suggests that probe-cluster intensity does not perfectly predict probe-cluster consistency.
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douts were quantile normalized to abstract away correlation
among probes generated by inter-sample systematic bias.
Then, the consistency score of each probe was set to the 90th
percentile of computed Pearson correlation coefficients
across its neighbors. Statistical significance was estimated on
a gene-per-gene basis using a null distribution generated by
computing the correlation between the probes mapping to the
gene and 1,000 probes selected uniformly at random. Probes
with consistency score corresponding to P > 0.01 were dis-
carded (Figure 1a).
Step 2: probe clusters
Neighboring probes that map to isoforms that are differenti-
ated by alternative splicing, RNA editing, or non-representa-
tive hybridization can produce readouts of different
molecular species leading to poor quantitative intensity eval-
uation for the probe cluster. To account for RNA isoforms, we
constructed transcript-focused probe clusters by performing
a non-supervised, single-linkage hierarchical clustering of the
probes using Pearson correlation coefficient as a distance
measure. First, clusters were formed by iteratively breaking
dendrogram edges that were significantly longer than the
remainder of the edges in each level according to a one-tail t-
test threshold of P < 10-10 (Figure 1b, c). Then, we iteratively
merged cluster pairs with distance significance greater than
0.001, where distance between clusters was defined as the
distance between the closest elements across clusters, and
significance was estimated using a null distribution of
1,000,000 distances between randomly selected probe pairs.
For illustration, Figure 1d depicts the two probe clusters iden-
tified for MAX across three of its known isoforms.
Step 3: probe cluster consistency
Low information probe clusters, composed of few or depend-
ent probes, were eliminated to reduce the false discovery rate
(FDR). Overlapping probes account for 87.2% of the U95av2
remapped probes and 66.1% of the U133plus2 remapped
probes, and they are affected by systematic bias resulting
from common technical artifacts and cross-hybridization.
These biases artificially improve pairwise correlations across
expression profiles and can be estimated by conditioning on
probe-overlap size. Figure 1e pictorially demonstrates that
pairwise Pearson correlations between probes can be
described as an exponential function of their overlap size; we
found this significant behavior to hold true across platforms
and experiments. To assign consistency scores for probe clus-
ters, we derived a score for computing the contribution of
each probe according to the size of its overlap with its
upstream neighbor. Each probe contributed at most one point
to the total score, and the contribution of a probe that over-
laps another upstream probe was accounted for according to
s(x):
where x is the shortest distance between probe starting posi-
tions across isoforms (position shift in Figure 1e); a, b and c
are estimated by fitting f(x) to pairwise Pearson correlations
for 1 ≤ x ≤ 24. We estimated the probe-cluster FDR for each
consistency score using permutation testing, where each
probe cluster constructed after permuting sample labels
(individually for each probe) was considered a false positive
detection. For all experiments reported in this study, we set
the minimum probe-cluster consistency score to s(x) ≥ 3. As
shown in Figure 1f, this minimum score corresponds to FDR
<5e-03 for the U95av2 B-cell samples.
Minimum sample size
To estimate the sample-size effect on Cleaner analysis, we
randomly selected subsets from the 152 U95Av2 and 200
U133plus2 microarray experiments in B cells, and estimated
the FDR when constructing probe clusters with Cleaner; we
selected 20 samples per sample size. Results suggest that
Cleaner is not effective for analyzing data derived from fewer
than 20 microarray experiments. FDR and probe-cluster
sizes showed no significant change for expression sets con-
sisting of 40 or more microarray experiments, suggesting that
full statistical power is obtained at this size (Figure S1 in Addi-
tional file 1). We note that we have obtained encouraging
results using datasets with as few as 30 samples; these are
described later in this section.
Probe sets generated by Cleaner for U95Av2 and U133plus2 
platforms
Cleaner rejects probes due to poor matches to RefSeq tran-
scripts and poor fit to a consistent probe cluster. Table 1
describes the total number of probes available, the number of
probes retained by Cleaner, and the number of Cleaner probe
clusters when measuring B-cell expression using U95Av2 and
U133plus2. To demonstrate that similar efficiency was
observed in other tissues, we provide the analogous informa-
tion for lung, ovary, glioblastoma multiforme, prostate and
breast carcinoma samples (Additional file 2). Poor gene
matching, due to no- or multiple-gene homology, resulted in
a loss of 23% and 47% of the probes for U95Av2 and
U133plus2, respectively (Remap in Table 1). Probe and probe-
cluster consistency analysis further discarded 48% and 67%
of the RefSeq-mapped probes in U95Av2 and U133plus2,
respectively. Cleaner eliminated most of the original probes,
and represented approximately half of the probed genes by at
least one probe cluster.
Of the probes discarded due to consistency issues, 55% and
58% were originally mapped to genes containing no consist-
ent probes on U95Av2 and U133plus2 platforms, respectively
(Figure S2 in Additional file 1), possibly reflecting the lack of
detection of the given transcripts. In fact, we observed a rela-
tionship between expression intensity and probe-cluster con-
sistency (Figure 1g). However, while low-intensity probe
clusters are significantly more likely to be eliminated, low
intensity on its own is not a sufficient requirement for rejec-
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tion: many high-intensity probe clusters get discarded and
low intensity probe clusters kept. In total, over 40% of the dis-
c a r d e d  p r o b e s  w e r e  m a p p e d  t o  i s o f o r m s  w i t h  c o n s i s t e n t
probe clusters, suggesting that individual probes mapped to
expressed genes can be inconsistent due to technical bias
(Figure S2 in Additional file 1). Finally, a small proportion of
remapped probes aligned to RefSeq transcripts with a single
mismatch, and Cleaner eliminated these imperfectly match-
ing probes at a significantly higher rate than that of perfectly
matching probes. Consequently, imperfectly matching probes
accounted for a very small portion of the consistent probes in
Cleaner probe clusters.
Agreement across technical replicate experiments
Repeatability of experimental results is one of the basic
requirements of any technology used for research and prod-
uct development. We show that experimental repeatability is
highly influenced by probe-set annotation quality. We meas-
ured Spearman correlation between replicate experiments
from GeneAtlasV2 for 30 human tissue samples using
Affymetrix, AffyProbeMiner and Cleaner annotation. Corre-
lation coefficient distributions are given in Figure 2 and dem-
onstrate that experimental replicate agreement shows a
marked improvement when using Cleaner probe-cluster
annotation. To eliminate potential circularity, Cleaner probe
clusters were constructed in each of the 30 sample sets sepa-
rately. In total, 79% of all consistent probes according to at
Table 1
Number of probes, probe sets, probe clusters and genes represented on two popular Affymetrix GeneChip microarrays
Affymetrix APM Remap Cleaner
U95Av2 Probes 200,073 163,939 (82%) 154,485 (77%) 83,862 (42%)
Probe-sets 12,625 9,130 (72%) 8,410 (67%) 6,011 (48%)
EntrezID 8,975 8,781 (98%) 8,410 (94%) 5,923 (66%)
U133plus2 Probes 594,532 326,265 (55%) 318,978 (54%) 153,960 (26%)
Probe-sets 54,675 19,887 (36%) 18,303 (33%) 12,162 (22%)
EntrezID 20,327 18,596 (91%) 18,303 (90%) 11,728 (58%)
We report the number of probes, probe-sets, probe clusters and unique EntrezIDs for the U95av2 and U133plus2 platforms according to 
Affymetrix, AffyProbeMiner (APM), Remap, and Cleaner annotation. Remap is the first stage of Cleaner, and here it is used to report the number of 
probes with homology to RefSeq transcripts and the number of probe sets and genes with at least one probe homolog. For simplicity of 
presentation, we refer to Remap and Cleaner probe clusters as probe sets in this table.
Consistency across technical replicate experiments Figure 2
Consistency across technical replicate experiments. Density distributions for the Spearman correlation coefficient across technical replicates considering: 
(a) all the probe clusters generated by each method (size in parenthesis); (b) only the 1,000 probe clusters with the highest sample variation for each 
method; and (c) only probe clusters corresponding to genes that were detected by all methods. Cleaner probe clusters show dramatically better 
agreement across technical replicates even after pruning out low variability probe sets (b), and when restricting the comparison to genes that are present 
in all annotation strategies (c). Remap-only probe sets were statistically indistinguishable from AffyProbeMiner probe sets; both probe sets showed 
significantly better agreement across technical replicates than Affymetrix probe sets in (a, c), but the three were statistically indistinguishable after pruning 
out low sample variation probe sets (b).
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least one of the annotations were included in probe clusters in
both annotations. Correlations were computed for genes with
exactly one probe cluster annotation.
To better quantify the distinct role of probe-remapping and
probe-correlation analysis (consistency-testing), we included
results taken at an intermediary step of the Cleaner algorithm
(Remap-only in Figure 2), where RefSeq-mapped probes
were used for probe-cluster construction. Results show that,
without consistency-testing, the difference between Cleaner
and AffyProbeMiner analyses is not statistically significant
(at P ≤ 0.05; Figure 2a). This suggests that Cleaner's improve-
ments are mostly due to the elimination of inconsistent
probes and to the construction of intrinsically consistent
probe clusters rather than to an improved genome-probe
mapping. In addition, to demonstrate that probe-set level
pruning does not bridge the performance gap between
Cleaner and the other annotations, we selected the 1,000
probe sets with highest coefficient of variation across samples
for each annotation and repeated the comparison (Figure 2b);
coefficient of variation-based pruning is commonly used to
remove poorly informative probe sets from microarray
expression experiments [20].
Finally, we restricted the comparison to genes with at least
four annotated probes according to each annotation method;
these genes had a sufficient number of consistent probes to
generate Cleaner probe clusters and therefore they were
expected to have accurate measurements according to all
methods. Surprisingly, correlation coefficient distributions
using Cleaner, AffyProbeMiner and Affymetrix annotation
were significantly different. Remapping probes to RefSeq
transcripts improved correlation across replicate experi-
ments, and removing remapped inconsistent probes further
increased correlation (Figure 2c). Our results suggest that
Cleaner probe clusters are significantly more consistent
across technical replicate experiments, and that the benefit of
its probe-level selection and pruning cannot be achieved
using probe-set level pruning.
Consistency across platforms
Differential expression analysis is routinely used to quantify
cross-platform consistency [8,20]. To measure consistency,
we identified differentially down-regulated genes in centrob-
last B-cell gene-expression profiles relative to naïve B-cell
gene-expression profiles. Such genes may contribute to
mature B-cell germinal-center formation. In order to discover
them, samples in five biological replicates for naïve and for
centroblast B cells were hybridized to Affymetrix GeneChip
U95Av2 and later to U133plus2 microarrays [10,21]. We
measured the consistency of differentially expressed gene sets
across the two platforms, and the FDR of down-regulation
calls in each platform under Affymetrix, AffyProbeMiner, and
Cleaner probe-cluster annotation. Figure 3 shows that
U133plus2-based analysis was consistently more accurate
than U95Av2-based analysis, and that Cleaner produces sig-
nificantly and dramatically more accurate intra- and inter-
platform results.
To identify centroblast down-regulated gene candidates, we
used a z-value cutoff of 2.33 (P < 0.01) for calling down-regu-
lation together with an added 1.5-fold change requirement.
Permutation testing estimates for the FDR in the U133plus2
a n a l y s i s  w e r e  1 0 . 7 % ,  5 . 4 %  a n d  3 . 2 %  f o r  A f f y m e t r i x ,  A f f y -
Cross-platform consistency for differential expression analysis Figure 3
Cross-platform consistency for differential expression analysis. Comparison of cross-platform consistency (U95Av2 versus U133P2), and estimated 
individual accuracy of differential expression calls using Cleaner (red), AffyProbeMiner (blue) and Affymetrix (black) annotation. Comparisons are made as 
a function of the z-value threshold used for identifying differentially down-regulated genes (x-axis). (a) Cross-platform consistency was measured as the 
proportion of genes that are called down-regulated by both platforms to genes that are probed by both platforms and are called down-regulated by at least 
one of the platforms. (b) Accuracy of individual experiments was measured using FDR estimates from permutation testing, where all probe clusters scoring 
above threshold in the original data are called true positives and all probe clusters identified in permutated data are called false positives.
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ProbeMiner, and Cleaner probe-cluster annotation, respec-
tively. Focusing on genes probed by both U95Av2 and
U133plus2 platforms, we identified 859 and 1,234 down-reg-
ulated genes in centroblasts by using Affymetrix annotations;
742 and 989 down-regulated genes by using AffyProbeMiner;
and 677 and 801 down-regulated genes when using Cleaner.
For Affymetrix annotation, 1,478 genes were called down-reg-
ulated by at least one of the platforms and 615 (41.6%) genes
w e r e  c a l l e d  d o w n - r e g u l a t e d  i n  b o t h  p l a t f o r m s ;  t h i s  r a t i o
improved to 550 of 1,181 (46.6%) for AffyProbeMiner, and to
562 of 919 (61.2%) for Cleaner. Finally, only 394 genes were
called down-regulated by all annotations on all platforms.
Note that enrichment results are independent of the actual
number of differentially expressed genes identified in each
method and each platform. U133plus2 included more probes,
more probe sets, and more probe clusters and it was consist-
ently more accurate. The most accurate results were pro-
duced using Cleaner, which defined the fewest probe clusters.
To conclude, we note that according to differential expression
analysis, expression consistency across platforms when using
Cleaner annotation (61.2%) was 50% better than when using
Affymetrix annotation (41.6%).
Identification of biased probes
To demonstrate that Cleaner consistency testing is sufficient
to identify biased and poorly designed probes, we focused on
two types of probe features that are known to affect accuracy:
G-spot probes and probes matching the transcript antisense.
G spots have been shown to bias expression measurements
[22], although not all probes containing G spots are flawed;
we showed that Cleaner preferentially discards G-spot
probes. Probes matching the antisense of transcripts are at
best noisy and at worst hybridizing with the wrong gene; we
temporarily included anti-sense probe alignments when rem-
apping probes, and showed that Cleaner discards almost all
antisense probes.
We used DME and motifclass [23] to identify patterns that
are enriched in sequences of discarded probes relative to
sequences of consistent probes. To ensure that discarded
probes were truly individually inconsistent and were not dis-
carded due to obsolete genomic annotation or poorly
expressed target genes, we restricted the study to consistent
probe-clusters corresponding to genes that had less than 20%
probe rejection rates. The most enriched motifs identified
were CGGGGG and GGG [G|A] [G|C]; both motifs were sig-
nificantly (P < 0.001) enriched according to permutation test-
ing, and CGGGGG had sites in 46% of the inconsistent probes
and 20% of the consistent probes. This result suggests that
patterns such as G spots are strongly correlated with probe
bias, but may not be sufficient criteria for probe selection and
pruning. Twenty percent of the consistent probes included a
CGGGGG substring but still showed significant correlation to
neighboring G-spot-free probes. Thus, correlation analysis
discriminates between biased and faithful probes independ-
ent of the source of the bias and outperforms feature-specific
analysis.
Both Affymetrix and AffyProbeMiner probe-set annotations
include probes that match the antisense orientation of genes
(see discussion about FOXM1 probe set 41324_g_at for an
example). Cleaner does not permit antisense remapping;
however, in order to test Cleaner's ability to identify incon-
sistent probes, we temporarily allowed antisense remapping.
Antisense remapping of U95Av2 and U133plus2 probes iden-
tified 6,521 and 21,000 probes with unique homology to the
reverse strand of RefSeq transcripts. Cleaner found that 6,013
(92%) of the U95Av2 and 18,511 (88%) of the U133plus2 anti-
sense probes are inconsistent. For the majority of probes,
antisense mapping should not produce clear and stable sig-
nals across profiles, and indeed Cleaner was able to recognize
the vast majority of these poorly designed probes.
Inconsistent behavior of Affymetrix probe sets
U95Av2 and U133plus2 Affymetrix annotations include 2,168
and 10,895 genes with multiple probe-set definitions. Same-
gene probe sets exhibit varying expression estimates: 3,840
of 4,344 and 35,873 of 43,285 probe-set pairs were positively
correlated across B-cell samples as measured using U95Av2
and U133plus2 expression arrays. Of these, only 1,780 (46%)
and 14,157 (39%) were significantly correlated (P < 0.01; Fig-
ure S3 in Additional file 1). Not surprisingly, Cleaner annota-
tions include substantially fewer genes with multiple probe
clusters: 89 and 541 for U95Av2 and U133plus2, respectively.
Given reliable and consistent probe clustering, alternative
probe sets can be used to capture variably expressed isoforms.
However, when confidence in probe-set construction is low,
the existence of poorly agreeing probe sets is not necessarily
related to alternative isoforms. To demonstrate the challenge
presented by multiple probe sets per gene, we focused on two
genes associated with multiple probe sets in Affymetrix anno-
tation.  FOXM1  is represented by three probe sets in the
U95Av2 platform, two of them showing a weak correlation
across the B-cell samples and the third anti-correlated with
the first two. MYB is associated with eight probe sets, six of
them strongly correlated and two showing a weak correlation
(Figure 4a). From these, only one probe set per gene was
identified as up-regulated in centroblasts at P < 0.01 (Figure
4b). On the whole, only 207 (10%) and 1,452 (13%) of 2,168
and 10,895 genes profiled using U95Av2 and U133plus2
expression arrays had multiple differentially expressed probe
sets, which is consistent with previously described poor
agreements between probe sets that are associated with the
same gene.
To identify which of the Affymetrix probe sets and Cleaner
probe clusters are accurately estimating FOXM1 and MYB
gene expression, we knocked-down the two genes and com-
pared their transcript levels using qRT-PCR and expression
profiling on the U95Av2 platform. We used the Cleaner probe
clusters constructed using the B cell sample data (Table 1).http://genomebiology.com/2009/10/12/R143 Genome Biology 2009,     Volume 10, Issue 12, Article R143       Alvarez et al. R143.8
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The knock-down of both genes was confirmed at the mRNA
and protein levels by a qRT-PCR reaction designed to detect
all known splicing variants and by immunoblot (Figure 5a, b).
Results given in Figure 5c show that only one probe set for
FOXM1 and five highly correlated probe sets for MYB (Figure
4a) agree with the qRT-PCR results at a two-fold threshold.
Probe sets that indicated FOXM1 and MYB down-regulation
in germinal center (Figure 4b) also indicated up-regulation
after short hairpin RNA (shRNA)-mediated knock-down
(Figure 5c). Cleaner probe clusters conclusively indicated up-
regulation for the two genes in germinal center (Figure 4b),
and down-regulation for the two genes after shRNA-medi-
ated knock-down (Figure 5c).
Interestingly, the six MYB  probe sets responding to MYB
knock-down contributed to the Cleaner cluster, while all but
two probes from the non-responding probe sets were dis-
carded during the remapping process (Figure 5c). The two
remapped probes for the conflicting MYB probe set 41854_at
were discarded at a later stage by Cleaner consistency analy-
sis. Similarly, the FOXM1 probe set responding to FOXM1
knock-down was the only one contributing to the Cleaner
cluster, while all the probes for the remaining probe-sets were
discarded during the remapping process (Figure 5c). An
expanded probe-by-probe description of Figure 5c can be
found in Additional file 3. Probe alignment locations to the
two genes, as well as shRNA and qRT-PCR primer target loca-
tions, are given in Figure S4 in Additional file 1. Note that the
FOXM1 probe set 41324_g_at aligns to the reverse comple-
ment (antisense) of the gene and is not included in the set of
remapped probes in Figure 5c. We included the probe set in
Figure S4 in Additional file 1 as an example for antisense rem-
apping and, as expected, inclusion of these probes in the rem-
apping stage only resulted in their elimination by Cleaner due
to low consistency scores.
Finally, in Figure S5 in Additional file 1 we report on a breast-
carcinoma-specific test comparing HER2 protein presence
and HER2 mRNA expression estimates by three Affymetrix
probe sets and one Cleaner probe cluster. HER2 protein was
detected in 31 of the 129 samples [24], and using gene set
enrichment analysis we showed that while estimates by all
three Affymetrix probe sets are significantly correlated with
the presence of the protein, the Cleaner probe cluster pro-
vides the closest estimates.
Discussion
Large scale gene expression profiles are used for applications,
including constructing high quality gene networks and inter-
action maps [10,11], improving the efficiency of drug target
identification [25], developing diagnostic methods for disease
stratification [26], and improving the understanding of the
factors contributing to physiologic and pathologic differences
between cellular phenotypes [21]. Nonetheless, repeatability
of gene-expression measurements is still a major issue, with
consistency of differential-expressed gene calling in repeated
assays or across platforms below 50%. Worse, our results
show that, on average, expression array probes that are over-
lapping in all but one position on the same transcript achieve
Pearson Correlation below 0.85 (Figure 5e). These issues,
which are related to probe-degeneracy, post-transcriptional/
sample-specific modifications, and experimental sample
preparation are broad and will continue to affect even deep-
sequencing-based gene-expression profiling methods. Addi-
tionally, there are intrinsic limits for the consistency of even
Inconsistent behavior of Affymetrix probe sets Figure 4
Inconsistent behavior of Affymetrix probe sets. (a) Correlation matrix for the Affymetrix annotated probe-sets associated with FOXM1 and MYB on the 
U95Av2 platform. The color scale, from blue to red, depicts the correlation (Pearson correlation coefficient) between probe sets. (b) Differential 
expression between centroblasts and naïve B cells as measured by FOXM1 and MYB probe-sets; P-values were estimated by U test and the color scale is 
used to emphasize significant differential expression and up-regulation.
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technical replicates due to experimental error. While existing
methods operate well below that theoretical threshold,
Cleaner achieves reproducibility that is closer to the theoreti-
cal limit and addresses most of the other issues by discarding
non-informative probes without sacrificing dynamic range
(that is, discarding low-intensity probes). Indeed, consistent
low-intensity probes can be more informative than many
inconsistent high-intensity ones. We suggest that transcript-
level measurement-accuracy can be efficiently improved by
clustering multiple informative probes, a design that will fur-
ther benefit from the introduction of deep-sequencing-based
approaches.
Technology that uses multiple probes per target to estimate
expression can take advantage of large-scale gene expression
profiling to improve accuracy. We showed that testing probe
consistency across individual measurements helps identify
biased or uninformative probes, leading to increased accu-
racy when estimating expression intensities on the transcript
and gene levels. Using relatively simple statistics, we were
able to resolve ambiguity and correct for bias with no concern
for its source. Moreover, we showed that pruning measure-
ment estimates for probe sets rather than for individual
probes will inevitably lead to discarding high-quality probes
because their aggregates include polluting poor-quality
probes. In comparison, data analysis that is focused on indi-
vidual probes can eliminate non-informative expression esti-
mates for both probes and probe clusters, thus constructing
clean clusters and simultaneously and efficiently reducing
data dimensionality. This last point is crucial for improving
the power of downstream data analysis such as biomarker
discovery, phenotype classification, and reverse engineering
of transcriptional networks [10,20,27,28].
Due to poor mapping to RefSeq genes, poor consistency, low
gene expression or low variability across experiments, we dis-
Probe-sets accurately reporting FOXM1 and MYB transcript levels Figure 5
Probe-sets accurately reporting FOXM1 and MYB transcript levels. (a) mRNA levels for FOXM1 and MYB by qRT-PCR 24 h after lentiviral-mediated 
shRNA expression of a non-target sequence (NT; black bars); FOXM1- and MYB-specific sequences are shown by white bars. (b) FOXM1 and MYB protein 
levels by immunoblot 24 h after lentiviral-mediated shRNA expression of a non-target sequence (Control), and FOXM1- and MYB-specific sequences. (c) 
Affymetrix probe sets associated with FOXM1 and MYB transcripts fail to conclusively describe the effects of shRNA-mediated silencing. After FOXM1 and 
MYB silencing, some Affymetrix-annotated probe sets suggest mild increase in FOXM1 (two of three) and MYB expression (one of eight). Probe remapping 
to RefSeq transcripts and Cleaner annotation suggest that probes assigned to these probe sets either fail to match target genes or are inconsistent. As a 
result, Cleaner produced single probe clusters that correctly capture the shRNA-mediated knock-down validated by qRT-PCR.
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carded most of the individual probe measurements in each
Affymetrix gene chip. We retained probe-cluster representa-
tions for approximately half of the genes that were originally
included in the array design. The loss of probe-level data was
offset by dramatic improvements in measurement accuracy
for the remaining probed genes. Our analysis suggests that
the vast majority of data discarded is at best uninformative
for downstream analysis, as in the case of unexpressed tran-
scripts, and at worst reduces the accuracy of otherwise good
probe clusters, as in the case of inconsistent individual
probes. Namely, if a probe is affected by systematic bias, then
transcript intensity estimates that disregard this probe and
are solely based on faithful probe measurements will be more
accurate.
In this study we analyzed large-scale expression profiles
obtained using Affymetrix microarrays, which have been used
to produce a variety of large-scale, publicly available datasets.
However, our methodology extends to other technologies that
use multiple probes per target, including exon arrays and
deep sequencing. Ideas developed here for expression arrays,
including overlapping probe analysis and isoform identifica-
tion, are easily adapted to resolve probe dependence in data
produced by other technologies.
Cleaner is directly applicable for analyzing Affymetrix exon
arrays and is expected to produce alternative clusters for a
larger set of genes. Figure 6 illustrates six examples of Cleaner
probe clusters associated with known transcript isoforms
(FAM13A, ELMO1, TPD52L2, INO80C) and Cleaner pre-
dicted isoforms (GATA6 and MAPK8IP1) using expression
data from 55 human glial brain tumor samples hybridized on
huex10stv1 Affymetrix exon arrays [29]. Note that alternative
cluster probe positions for TPD52L2 and INO80C are inter-
leaved. To emphasize that expression estimates for the alter-
native probe clusters are indeed very different, we compare
expression estimates using the alternative clusters for the six
genes in Figure S6 in Additional file 1.
Deep-sequencing reads are particularly amenable to the
Cleaner approach. Understanding the relationship between
reads and estimating the consistency of reads helps estimate
target isoform concentration, and allows for eliminating or
reevaluating biased and complex reads. Such reads include
overlapping reads, reads that map to multiple transcripts,
and reads that are biased due to features such as base compo-
sition or uneven copy number. In addition to technology-
independent challenges addressed here, deep-sequencing
data with sufficient coverage and dataset size will permit a
more specific mixture resolution and the estimation of the
contribution of individual sources producing observed read
volumes. To extend the Cleaner method to deep-sequencing
technology, partition RefSeq transcripts into equal-size bins,
where the number of bins depends on the reads per transcript
kilobase across samples. Each bin is scored based on the
number of overlapping tags, and bins are treated as quasi-
probes. Instead of using the distance between probes to score
probe-cluster consistency, use the distance between bins. The
rest of the algorithm directly follows Cleaner's current meth-
odology.
Conclusions
Genome-wide gene expression profile data suffer from tech-
nology-driven and technology-independent systematic bias.
Measurement multiplicity, which is implicit to gene expres-
sion profiling technologies using multiple probes per target,
can be used to assemble informative, transcript-specific
probe-clusters that dramatically improve expression esti-
mates in large cell-context-specific datasets. By harvesting
the power of large-scale expression profiling we accounted for
systematic biases regardless of their source. Our methods can
be used to analyze both the large body of data in current
repositories, and due to their technology-independent
nature, they can be extended to construct transcript-specific
probe-clusters using exon-array data and transcript-specific
read-clusters in deep-sequencing data.
Materials and methods
Cell lines and cell culture conditions
We maintained ST486 and 293FT cells in Iscove's modified
Dulbecco's medium (IMDM; Invitrogen, Carlsbad, CA, USA)
and Dulbecco's minimum essential medium (DMEM; Invit-
rogen), respectively. Culture media was supplemented with
10% fetal bovine serum (Invitrogen) and 1% penicillin-strep-
tomycin (Cellgro, Herndon, VA, USA).
Lentiviral-mediated transduction
Control shRNA (SHC002), FOXM1  shRNA
(TRCN0000015546) and MYB shRNA (TRCN0000040062)
cloned into pLKO.1-puro lentiviral vector (Sigma, St Louis,
MO, USA) were individually co-transfected with vesicular
stomatitis virus glycoprotein envelope plasmid (280 ng) and
Δ8.9 packaging vector (2.5 μg) into a subconfluent 100-mm
plate of 293FT cells using Fugene 6 (Roche, Indianapolis, IN,
USA). The viral particles were collected at 48 h and 72 h post-
transfection and concentrated by ultracentrifugation in a
Beckman SW28 rotor at 25,000 rpm for 1.5 h. ST486 cells (5
× 106) were transduced with the viral particles in the presence
of 8 μg/ml polybrene (Chemicon, Billerica, MA, USA) by cen-
trifugation at 450 g for 1.5 h.
Sample processing for qRT-PCR and microarrays
Total RNA was extracted with Trizol (Invitrogen) and purified
by RNeasy kit (Qiagen, Valencia, CA, USA). For qRT-PCR,
total RNA was reverse transcribed by QuantiTect Reverse
Transcription kit (Qiagen) and SYBR-Green based qRT-PCR
analysis was performed on an ABI7300 Real-time PCR sys-
tem (Applied Biosystems, Foster City, CA, USA) using Quant-
iTect SYBR-Green kit (Qiagen). Relative quantification was
performed with the 2-ΔΔCt method [30], and was normalizedhttp://genomebiology.com/2009/10/12/R143 Genome Biology 2009,     Volume 10, Issue 12, Article R143       Alvarez et al. R143.11
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by GAPDH expression by using the forward and reverse prim-
ers CACTGGGCCCTGACAACATC and TCACTCAGAGCTT-
GGGGTG for FOXM1, TGGGAGATGTGTGTTGTTGATG and
TCCATGCAACAGTTCTGAGACC for MYB, and CACCCA-
GAAGACTGTGGATGGC and GTTCAGCTCAGGGATGAC-
CTTGC for GAPDH. For microarray-based gene expression
profiles, 5 μg of total RNA were processed following the man-
ufacturer's instructions (Affymetrix, 701025 Rev.6), and 15 μg
of fragmented and biotin-labeled cRNA were hybridized to
HG-U95Av2 microarrays (Affymetrix, Santa Clara, CA, USA).
Immunoblots
Whole cell lysates were prepared from ST486 cells by using
RIPA buffer (Teknova, Hollister, CA, USA) with Complete
Mini protease inhibitor cocktail (Roche). Proteins were frac-
tionated by SDS-PAGE and analyzed by standard immunob-
lotting procedures using the following antibodies: anti-
FOXM1 (sc-502), anti-MYB (sc-517) and anti-GAPDH (sc-
32233), all from Santa Cruz (Santa Cruz, CA, USA).
Cleaner probe clusters for six genes profiled on an exon array Figure 6
Cleaner probe clusters for six genes profiled on an exon array. Examples of putative Cleaner mRNA isoforms identified by using 55 human glial brain 
tumor samples hybridized on huex10stv1 Affymetrix exon arrays. The plots show the hybridization position for each probe on known and predicted 
mRNA isoforms for each gene.
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Expression profiles
Gene expression data include 102 B-cell samples profiled on
U95A [10], 152 B-cell samples profiled on U95Av2 [10], 75
lung carcinoma samples on U95Av2 and U133plus2 [31,32],
51 and 295 ovarian cancer samples on U95Av2 and
U133plus2 [33,34], 49 and 45 glioblastoma samples on
U95Av2 (GSE13041) and U133plus2 [35,36], 88 and 154
prostate cancer samples on U95Av2 and U133plus2, 40 and
129 breast carcinoma samples on U95Av2 and U133plus2
[24,37], 200 B-cell samples profiled on U133plus2 [21], 60
samples from 30 human tissues profiled on U133A chips [38],
and 55 human glial brain tumor samples hybridized on
huex10stv1 Affymetrix exon arrays [29]. All samples were
obtained from the GEO database [16] and GeneAtlasV2 [38].
A Bioconductor-based [39] implementation of MAS5 [40]
was used to quantitatively estimate and normalize the inten-
sity levels of probe clusters. Affymetrix annotation data were
obtained from Bioconductor metadata packages hgu95av2.db
and hgu133plus2.db v2.2.5 [39].
Differential expression
We used a non-parametric U-test to identify down-regulated
genes in centroblast B cells relative to naïve B cells. Compar-
isons were made using expression profiles from five biological
replicates in each cell type. To identify a representative set of
down-regulated genes per platform and annotation method,
we used a z-value cutoff of 2.33 (P < 0.01) for calling differen-
tial expression together with a 1.5-fold change requirement.
The fold change requirement was used in order to correct for
the high expected FDR of this non-parametric test across
thousands of probe clusters when using only five biological
replicates for each cell type. The 1.5-fold decrease from naïve
to centroblast B cells was based on the average intensities of
the probe clusters after MAS5 normalization and log2 trans-
formation. Analysis accuracy was measured using permuta-
tion testing repeated 20 times per annotation and platform,
where the experimental source labels were shuffled for each
probe cluster.
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